Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roderich E Schwarz

Showing results (81-90 of 109) with videos related to

Pageof 11
Sort By:
Translational Oncology|February 24, 2018
Superior Therapeutic Efficacy of Nanoparticle Albumin Bound Paclitaxel Over Cremophor-Bound Paclitaxel in Experimental Esophageal AdenocarcinomaMd Sazzad Hassan, Niranjan Awasthi, Jun Li, et al.
Molecular Cancer Therapeutics|May 23, 2013
PG545, an angiogenesis and heparanase inhibitor, reduces primary tumor growth and metastasis in experimental pancreatic cancerKatherine T Ostapoff, Niranjan Awasthi, Bercin Kutluk Cenik, et al.
Case Reports in Surgery|August 18, 2012
Rare hepatic arterial anatomic variants in patients requiring pancreatoduodenectomy and review of the literatureSmita Ramanadham, Seth M Toomay, Adam C Yopp, et al.
American Journal of Surgery|September 6, 2018
Physician derived versus administrative data in identifying surgical complications. Fact versus FictionLeonard R Henry, Michael J Minarich, Rhonda Griffin, et al.
Hepato-Gastroenterology|March 14, 2014
Evaluation of skeletonization of the hepatoduodenal ligament for the lower third gastric cancer by propensity score analysisZhe-Wei Wei, Guang-Kai Xia, Ying Wu, et al.
World Journal of Gastroenterology|June 8, 2013
Efficacy of adjuvant XELOX and FOLFOX6 chemotherapy after D2 dissection for gastric cancerYing Wu, Zhe-Wei Wei, Yu-Long He, et al.
Digestive Diseases and Sciences|December 10, 2013
Impact of pre-existing type-2 diabetes on patient outcomes after radical resection for gastric cancer: a retrospective cohort studyZhe-Wei Wei, Jia-Ling Li, Ying Wu, et al.
Molecular Cancer Therapeutics|May 2, 2022
Augmenting Experimental Gastric Cancer Activity of Irinotecan through Liposomal Formulation and Antiangiogenic Combination TherapyNiranjan Awasthi, Margaret A Schwarz, Changhua Zhang, et al.
Carcinogenesis|June 28, 2013
Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancerNiranjan Awasthi, Changhua Zhang, Anna M Schwarz, et al.
Annals of Surgical Oncology|November 4, 2010
Phase I dose-escalation study of stereotactic body radiotherapy in patients with hepatic metastasesWilliam Rule, Robert Timmerman, Liyue Tong, et al.
Pageof 11

Showing results (81-90 of 109) with videos related to

Sort By:
Pageof 11
Translational Oncology|February 24, 2018
Superior Therapeutic Efficacy of Nanoparticle Albumin Bound Paclitaxel Over Cremophor-Bound Paclitaxel in Experimental Esophageal AdenocarcinomaMd Sazzad Hassan, Niranjan Awasthi, Jun Li, et al.
Molecular Cancer Therapeutics|May 23, 2013
PG545, an angiogenesis and heparanase inhibitor, reduces primary tumor growth and metastasis in experimental pancreatic cancerKatherine T Ostapoff, Niranjan Awasthi, Bercin Kutluk Cenik, et al.
Case Reports in Surgery|August 18, 2012
Rare hepatic arterial anatomic variants in patients requiring pancreatoduodenectomy and review of the literatureSmita Ramanadham, Seth M Toomay, Adam C Yopp, et al.
American Journal of Surgery|September 6, 2018
Physician derived versus administrative data in identifying surgical complications. Fact versus FictionLeonard R Henry, Michael J Minarich, Rhonda Griffin, et al.
Hepato-Gastroenterology|March 14, 2014
Evaluation of skeletonization of the hepatoduodenal ligament for the lower third gastric cancer by propensity score analysisZhe-Wei Wei, Guang-Kai Xia, Ying Wu, et al.
World Journal of Gastroenterology|June 8, 2013
Efficacy of adjuvant XELOX and FOLFOX6 chemotherapy after D2 dissection for gastric cancerYing Wu, Zhe-Wei Wei, Yu-Long He, et al.
Digestive Diseases and Sciences|December 10, 2013
Impact of pre-existing type-2 diabetes on patient outcomes after radical resection for gastric cancer: a retrospective cohort studyZhe-Wei Wei, Jia-Ling Li, Ying Wu, et al.
Molecular Cancer Therapeutics|May 2, 2022
Augmenting Experimental Gastric Cancer Activity of Irinotecan through Liposomal Formulation and Antiangiogenic Combination TherapyNiranjan Awasthi, Margaret A Schwarz, Changhua Zhang, et al.
Carcinogenesis|June 28, 2013
Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancerNiranjan Awasthi, Changhua Zhang, Anna M Schwarz, et al.
Annals of Surgical Oncology|November 4, 2010
Phase I dose-escalation study of stereotactic body radiotherapy in patients with hepatic metastasesWilliam Rule, Robert Timmerman, Liyue Tong, et al.
Pageof 11